G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
G.I. Windows has raised $37.0M in total funding. The most recent round was Series B. The last funding was announced in November 2024.
G.I. Windows's investors include Johnson & Johnson Innovation JJDC, Broadview Ventures, Rex Health Ventures, Sonder Capital, Orlando Health Ventures.
G.I. Windows is headquartered in Westwood, United States.
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
G.I. Windows is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"G.I. Windows — Funding & Investors." VCBacked, November 20, 2024, https://www.vcbacked.co/company/gi-windows. Accessed August 1, 2026.
VCBacked. (2024). G.I. Windows — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/gi-windows
{{cite web |title=G.I. Windows — Funding & Investors |url=https://www.vcbacked.co/company/gi-windows |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated